A ntibiotics are an essential component of the modern lifestyle. They improve our lives by treating disease, preventing disease, and in the case of agricultural animals by improving feed efficiency. However, antibiotic usage is not without collateral effects. The development and spread of antibiotic resistance is the most notorious concern associated with antibiotic use. New technologies have enabled the study of how the microbiota responds to the antibiotic disturbance, including how the community recovers after the antibiotic is removed. One common theme in studies of antibiotic effects is a rapid increase in Escherichia coli followed by a gradual decline. Increases in E. coli are also associated with systemic host stresses, and may be an indicator of ecosystem disturbances of the intestinal microbiota. Moreover, recent studies have shown additional effects mediated by antibiotics on the gut microbiota, such as the stimulation of gene transfer among gut bacteria and the reduction of immune responses in peripheral organs. Querying the microbiota after antibiotic treatment has led to intriguing hypotheses regarding predicting or mitigating unfavorable treatment outcomes. Here we explore the varied effects of antibiotics on human and animal microbiotas.
In the US, agricultural antibiotics are used for disease treatment, control, and prevention, but decades of use has led some to question the long-term safety of antibiotic usage in livestock and poultry production (i.e., performance-enhancing uses), particularly regarding those antibiotics that are important for human health. [1] [2] [3] Primary concerns surrounding antibiotic
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Torey Looft and Heather K. Allen* Food Safety and Enteric Pathogens Research Unit; National Animal Disease Center; Ames, IA USA use in agriculture are the development, dissemination, and persistence of antibiotic resistance genes in the bacterial communities associated both with the host and the environment. The discussion usually centers on antibiotic resistance genes in or transferred to pathogens because of their obvious implications for disease treatment, but the so-called collateral effect of antibiotics on a host and its associated microbial community (microbiota) should be an important part of the debate. Collateral effects are the undefined, unintended, or previously unknown effects that are secondary to the intended objectives of antibiotic use. In this review, we will leave the topic of resistance genes and pathogenic bacteria and instead discuss the breadth of additional collateral effects of antibiotics on host microbiotas, focusing on mammalian systems.
The mammalian gastrointestinal (GI) microbiota is comprised of a diverse collection of bacteria in a dynamic environment. As least 500 species are found in the human gut, 4 with up to 1,000 species found in the swine gut. 5 These diverse GI microbes are important for the maintenance of host health. They have important protective and metabolic functions, such as assisting the host in nutrient extraction, immune system and epithelium development, and are a natural defense against pathogens. 6 This vast array of GI bacteria responds to environmental conditions inside the host, 7 including antibioticinduced disturbances.
Except for performance-enhancing antibiotics in livestock and poultry production, both veterinary and medical antibiotics are typically administered to target particular bacterial pathogen(s). However, most antibiotics are either in the intestinal tract increases the susceptibility for enteric infections. 24 Specifically, certain members of the intestinal microbiota have been shown to inhibit enteric Enterobacteriaceae such as E. coli and Salmonella. 21, 25 Additionally, commensal Lactobacilli spp can induce secretion of intestinal mucins, inhibiting adhesion of enteropathogenic E. coli in vitro. 26 Cecal transplants from conventional to germfree mice initially result in reduced diversity of the transplanted community in the recipient, followed by an explosion on E. coli growth. In time the diversity recovered and E. coli returned to lower levels. 27 Disturbance resulting in dysbiosis and loss of members of the commensal community may contribute to unforeseen collateral damage, such as blooms of E. coli within the intestinal microbiota.
With a disturbance such as antibiotic administration, recovery depends on the antibiotic used, its dose, and its duration of administration. With one-time streptomycin administration in mice, the number of bacteria in the feces dropped 90% in the first 12 h, but rebounded to pre-treatment amounts by six days posttreatment. 28 In a microbial community analysis of humans over a longer time period that ended four weeks after the withdrawl of ciprofloxacin, the microbiota of the treated individuals merely resembled the pretreated state, and several taxa did not recover. 9 This is potentially concerning because loss of specific commensal bacteria may impact host health. For example, the bacterium Oxalobacter formigenes is lost after antibiotic treatment in humans and can be difficult to re-establish. 29 O. formigenes degrades oxalate, the accumulation of which results in the formation of calcium oxalate kidney stones. 30 The re-colonization of O. formigenes in hyperoxaluric (high blood oxalate) mice resulted in decreased urinary and blood oxalate levels, 31 implicating this commensal gut microbe in treating or even preventing hyperoxaluria. Indeed, it has been hypothesized that the gradual loss of specific members of our ancestral gut microbiota due to numerous modern practices, including antibiotic consumption, has caused the recent sharp increases in allergic and metabolic diseases in human medicine. 32 The long-term impacts of a administration. Increases of enteric E. coli have also been associated with exposure to many other antibiotics such as amoxicillin and metronidazole, 13 metronidazole alone, 14 and vancomycin and imipenem. 15 Additionally, E. coli bloomed in parallel with Salmonella in mice that were treated with streptomycin. 16 Throughout these examples, it is unclear if E. coli is increasing in abundance due to antibiotic resistance or other factors associated with the community disturbance (such as inflammation), but it is nonetheless intriguing that a wide array of antibiotic classes and administration methods elicits a common response.
Antibiotics are not the only perturbation that leads to an increased abundance of gastrointestinal E. coli. Additional stresses, including those directed by or at the host, have been shown to cause this phenomenon. Enteric E. coli are more abundant in pregnant women with excessive weight gain, 17 but a seemingly disparate example is elevated E. coli populations observed in starving Bangladeshi children 18 who obviously have no weight gain. A more invasive disturbance is surgery, which in mice increased both the abundance and the adherence of gut E. coli during the postsurgery recovery. 19 Additionally, models of inflammatory bowel disease have shown an association between E. coli blooms and disease onset. 20, 21 In livestock, E. coli is known to increase in abundance during weaning, which is a very stressful event for young animals. Indeed, one of the leading causes of post-weaning diarrhea and death in piglets is caused by enterotoxigenic E. coli (ETEC) infections. 22 Even a simple disturbance such as fasting can induce a population burst of commensal E. coli in cattle. 23 The various drivers of E. coli blooms might have a common theme in that they all impact the total intestinal bacterial community; E. coli may be capitalizing on a general disruption of the microbiota, temporarily expanding its niche in part due to its short doubling time.
Disturbances within the host ecosystem may disrupt gut microbial community homeostasis, resulting in reduction or loss of some members of the intestinal community. It has been suggested that reducing microbial diversity and richness injected or administered orally, thereby circulating throughout the host system and potentially affecting the entire microbiota. Next-generation sequencing technologies have been particularly powerful to view the comprehensive effects of antibiotics on mammalian microbiotas, in particular by using conserved phylogenetic markers (e.g., the 16S rRNA gene sequence) to make taxonomic assignments. 8 For example, 16S rRNA gene sequence analysis of the entire community revealed that the administration of ciprofloxacin to humans affected the majority of bacterial taxa in the gut, resulting in decreased richness (membership), diversity (membership and abundance), and evenness (numerical distribution of the members). 9 However, considering the breadth of antibiotics and their various targets, doses, and durations, it is not surprising that gut microbial communities respond to different antibiotics in different ways. In contrast to the ciprofloxacin example, oral administration of vancomycin to mice did not decrease the abundance of mucosally associated gut bacteria. 10 Discovering common patterns of antibiotic-induced changes in bacterial membership could be important indicators of general community disturbances.
Our recent study in swine used 454 technology to query the 16S rRNA gene sequence diversity and fecal metagenomes of six pigs over 14 d, before and after administration of ASP250 (chlortetracycline, sulfamethazine, and penicillin) in the feed. 11 We showed profound changes in the bacterial membership and functions with antibiotic treatment, including increases in Escherichia coli populations, certain antibiotic resistance genes, and clusters of functional genes related to energy production and conversion. We confirmed the E. coli increase in a separate study. 5 Investigation of the literature on antibiotic effects suggested that a bloom in commensal E. coli populations could be a response to a non-specific stress, including antibiotic treatment. Increased E. coli abundance was also detected in another swine study evaluating parenterally (non-GI) administered amoxicillin in piglets, 12 suggesting that the E. coli response is not specific to the route of antibiotic is difficult to treat with antibiotics and can result in the surgical removal of the colon, transplanting the fecal microbiota of a healthy person to the colon of a person infected with C. difficile is 90% effective at curing the disease. 45 The microbiota is therefore important both in preventing and treating certain bacterial pathogens. The mechanisms of how the microbiota functions in these capacities are unknown and should be a priority for further research.
Antibiotic alterations of the gut microbiota have also been linked to viral and fungal infections, and even have an impact on disease susceptibility in distal organs. Administering neomycin increased the susceptibility of mice to influenza infection in the lungs, indicating that inflammasome activation by neomycin-sensitive bacteria in the gut prevents influenza infections in the lungs. 45 This is an example of the commensal bacteria protecting against a viral infection, but the commensal bacteria can also directly or indirectly promote viral infection. 46 Infection by the mouse mammary tumor virus is only possible in the presence of the gut microbiota, even if the microbiota is of a random yet defined composition such as altered Schaedler's flora. 47 Additional opportunistic infectious agents that benefit from antibiotic treatment are fungi, which are notorious for causing infections in antibiotic-treated humans, particularly when the anaerobic gut bacteria are disturbed. 48 Administering tetracyline to rats caused the fungal pathogen Candida albicans to form significantly larger tongue lesions, although there was no significant difference in the number of lesions compared with infections in non-medicated rats. 49 Clearly there are situations in which the use of antibiotics is essential to treat disease, but the potential for secondary infections is a reminder that antibiotics should be used prudently.
Conclusions
The benefits of medical and agricultural antibiotic usage are straight-forward. However, the collateral consequences are complex and numerous. Negative side effects like the promotion of antibiotic resistance should be expected, but other microbial communities. 37 Phages are also important causes of food production losses as the leading causes of fermentation failure. 38 An impact of antibiotics on phages has been demonstrated in agricultural systems. The in-feed antibiotic carbadox is fed to swine for disease treatment and prevention against the causative agent of swine dysentery (Brachyspira hyodysenteriae). Sub-inhibitory concentrations of carbadox were shown to induce the phagelike gene transfer agent VSH-1 from B. hyodysenteriae, and indeed this phagelike element transduced chloramphenicol and tylosin resistance genes between B. hyodysenteriae strains. 39 In a later study, fecal phages were isolated from swine that were fed either carbadox or ASP250, and the phage metagenomes were sequenced. The phage metagenomes from medicated animals showed more integrase-encoding genes than those from the non-medicated animals, suggesting that in-feed antibiotics induced prophages from the bacterial community. 5 These studies demonstrate that antibiotics stimulate prophages or phage-like elements, which might transfer DNA; gene transfer is one mechanism of evolution. A further collateral effect of antibiotic treatment could therefore be the promotion of evolution among gut bacteria.
Although the purpose of most antibiotics is to prevent or treat a specific disease, some antibiotic use can actually increase susceptibility to certain bacterial pathogens. For example, reducing the numbers of commensal gut bacteria with broad-spectrum antibiotics can result in a reduction of host-produced antimicrobial molecules in the intestinal mucosa, increasing susceptibility to antibioticresistant bacteria and pathogens. 40, 41 One suggestion for how antibiotics such as metronidazole lead to increased gut infections is that they alter the mucus layer, thinning it and thereby weakening its barrier function. 42 The microbiota also benefits the host by displacing potential pathogens, 43 and community reductions due to antibiotics may reduce that capacity. A classic example of this is infection by Clostridium difficile, which is an opportunistic pathogen that frequently infects patients following antibiotic treatment for other conditions. Although the infection failed microbial recovery on host health are unclear but merit further study.
Alterations in bacterial membership have important implications on the functional capacity of the microbiota. Function-based studies are an important continuation of membership studies because they begin to address questions about what the bacteria in the community are doing, including benefits they may be providing the host. For example, particular changes in the bacterial communities may be associated with improved energy harvesting capacity of the gut microbiota after exposure to antibiotics. [33] [34] [35] [36] Changes in the relative abundance of Bacteroidetes and Firmicutes in obese individuals also reflect functional shifts toward increased energy harvesting within the microbial communities. 34, 36 Although performanceenhancing antibiotics do not promote obesity in animals, perhaps changes in metabolic activity due to microbial population shifts contribute to host metabolism. 33, 36 Building on studies of the functional capacity of the microbiota, transcriptomics and metabolomics are important tools for querying activity by asking what genes are transcribed and what metabolites are produced, respectively. In a landmark study of the effect of a one-time dose of the antibiotic streptomycin on the gut metabolome of mice, Antunes et al. 37 showed that over 80% of the detectable metabolites in feces showed altered abundance compared with those in the non-treated communities. Most of the affected metabolites discussed were critical for host physiology, including steroid hormone synthesis. This result suggests that streptomycin impacts the microbiota in such a way that certain hormone synthesis is affected, particularly that of steroids and eicosanoids, which might be important regarding their involvement in the inflammatory response in the gut. More studies such as these are needed to define the functional capacity of a microbiota and how it responds to and recovers from an antibiotic perturbation.
In addition to bacteria, bacteriophages are important members of the gut microbiota and are largely unstudied. Globally, phage predation on bacterial populations can impact biogeochemical processes, driving nutrient turnover and shaping effects of antibiotics on this ecosystem. Understanding the interplay among the host, the gut microbiota, and antibiotics will inform decisions on antibiotic usage and ultimately improve human and animal health. the feed, including the addition of acidifying agents. 50 This suggests that intestinal changes that result in increased E. coli populations could be mitigated with host diet management, including the use of alternatives to in-feed antibiotics such as organic acids. Antibiotic alternatives are an active area of research, both for validating existing alternatives and for developing novel approaches. New technologies have enabled the complexities of the intestinal ecosystem to be explored and provide insights into the extended changes in the host and its microbiota are harder to predict. It is important to remember that antibiotics aren't simply impacting a potential pathogen; they are also changing the ecology within the gut. One change detected following various disturbances is an increase in gut E. coli populations. Culturing fecal coliforms may be an easy and inexpensive way to monitor for dysbiosis in animals. Interestingly, the severity and duration of pathogenic E. coli infections in pigs at weaning can be reduced by altering the composition of
